Tyra Biosciences (TYRA) Capital Expenditures (2020 - 2026)
Tyra Biosciences (TYRA) reported Capital Expenditures of $20000.0 for Q1 2026, up 42.86% on a YoY basis from $14000.0 in Q1 2025, and down 53.49% quarter-over-quarter from $43000.0 in Q4 2025.
Tyra Biosciences (TYRA) Capital Expenditures (2020 - 2026) Analysis & Trends
Tyra Biosciences has reported Capital Expenditures for 7 years, with the latest figure at $20000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 42.86% year-over-year to $20000.0; the trailing twelve-month figure through Mar 2026 stood at $74000.0 (up 160.66% YoY), and the FY2025 full-year result was $68000.0, changed N/A from the prior year.
- Capital Expenditures for Q1 2026 stood at $20000.0, down from $43000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $470000.0 in Q2 2024, with the low at -$658000.0 in Q4 2024.
- Historically, Capital Expenditures has averaged $12529.4 across 5 years, with a median of $31000.0 in 2025.
- The largest YoY upside for Capital Expenditures was 993.02% in 2024 against a maximum downside of 1466.67% in 2024.
- Tyra Biosciences' Capital Expenditures stood at -$9000.0 in 2022, then plunged by 366.67% to -$42000.0 in 2023, then tumbled by 1466.67% to -$658000.0 in 2024, then soared by 106.53% to $43000.0 in 2025, then sank by 53.49% to $20000.0 in 2026.
- The last three Capital Expenditures figures came in at $20000.0 (Q1 2026), $43000.0 (Q4 2025), and -$20000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -63,220.27 |
| 10 | Tyra Biosciences | 1.67 Bn | 1.67 Bn | - | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Sep 30, 2025 | -20,000.00 |
| Sep 30, 2025 | -20,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | -658,000.00 |
| Dec 31, 2024 | -658,000.00 |
| Sep 30, 2024 | 52,000.00 |
| Sep 30, 2024 | 52,000.00 |
| Jun 30, 2024 | 470,000.00 |
| Jun 30, 2024 | 470,000.00 |
| Mar 31, 2024 | 136,000.00 |
| Mar 31, 2024 | 136,000.00 |
| Dec 31, 2023 | -42,000.00 |
| Dec 31, 2023 | -42,000.00 |